COUNTRY FOCUS: ISRAEL
“
SECTRA’S
SOLUTION WILL
OPTIMISE OUR
WORKFLOWS
THROUGH
STATE-OF-THE-
ART CLINICAL
TOOLS AND AI
INNOVATIONS.
At both healthcare providers, the solution
will be integrated with the laboratory
information system (LIS). This will provide
pathologists with a complete overview
of the patient history in one application
and enable workflow orchestration to
drive the reporting workflow according to
sub-specialties, rules and priorities. The
solution’s vendor-neutral approach also
gave the two healthcare providers the
freedom to select the scanner vendor of
their choice.
Sectra’s pathology solution is part of its
enterprise imaging offering. It provides a
unified strategy for all imaging needs and
improves patient outcomes while lowering
operational costs. The scalable and modular
solution, with a VNA at its core, allows
healthcare providers to grow from ology to
ology and from enterprise to enterprise.
As well as Sectra, Intel and Accenture have
also announced they are utilising technology
for healthcare innovation.
The technology vendors are supporting an
Intel Neuromorphic Research Community
(INRC) project led by the Neuro-Biomorphic
Engineering Lab at the Open University of
Israel in collaboration with ALYN Hospital.
Using funding and technology support from
Accenture, as well as Intel’s neuromorphic
technology and algorithmic support from
Applied Brain Research (ABR), the Israeli
research teams will develop a wheelchair-
www.intelligentcio.com
INTELLIGENTCIO
51